Blue Moose Spinach Artichoke Parmesan Dip, 7 oz. (198g), packed in a square, clear plastic container, six units in a pack, UPC 8 47847 00...
⚠ Critical Alert — Stop Using Immediately
This product has been flagged with severe risks (undeclared allergen). Stop using it now and contact the brand or FDA for a refund, repair, or replacement.
FDA Recall Notice
Source: U.S. Food and Drug Administration (FDA) — official FDA notice for recall FDA-F-1306-2022.
Spinach Artichoke Cashew Dip was mislabeled with Spinach Artichoke Parmesan Dip label and does not state that the product contains cashews and soy.
Corrective Action (per FDA)
Source: U.S. Food and Drug Administration (FDA) — official FDA notice for recall FDA-F-1306-2022.
Recall terminated by FDA.
✅ What you should do
- Stop using the product if you own it.
- Check the model number, lot code, or sell-by date against the recall notice above.
- Contact Blue Moose Of Boulder, Llc or the retailer where you bought it for a refund, replacement, or repair.
- For the most current official instructions, visit the FDA recall page.
- If you've been hurt by this product, report the incident to FDA.
Consumer Contact (per FDA)
Source: U.S. Food and Drug Administration (FDA) — official FDA notice for recall FDA-F-1306-2022.
Blue Moose of Boulder, LLC
About the U.S. Food and Drug Administration
The FDA regulates drugs, medical devices, food, cosmetics, and tobacco. Adverse event reports and recall notices are the main public safety signal.
Visit FDA.gov →📣 Report a food, supplement, or cosmetic problem to the FDA
If you had a reaction, found contamination, or experienced a labeling problem with this product, report it to the FDA. The agency uses consumer reports to track emerging safety signals and trigger recalls.
Blue Moose Of Boulder, Llc Recall FAQ
Blue Moose Of Boulder, Llc is the subject of a produce safety report: Blue Moose Spinach Artichoke Parmesan Dip, 7 oz. (198g), packed in a square, clear plastic container, six units in a pack, UPC 8 47847 00.... The notice was published on May 20, 2022 by the U.S. Food and Drug Administration (FDA). Approximately 572 units are potentially affected.